Required dose of sugammadex or neostigmine for reversal of vecuronium‐induced shallow residual neuromuscular block at a train‐of‐four ratio of 0.3
Abstract Residual shallow neuromuscular block (NMB) is potentially harmful and contributes to critical respiratory events. Evidence for the optimal dose of sugammadex required to reverse vecuronium‐induced shallow NMB is scarce. The aims of the present study were to find suitable doses of sugammadex...
Saved in:
Main Authors: | Jing He (Author), Huan He (Author), Xing Li (Author), Mei Sun (Author), Zhihao Lai (Author), Bo Xu (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Sugammadex Versus Neostigmine/Glycopyrrolate on Perioperative Efficiency
by: Deyhim N, et al.
Published: (2020) -
Sugammadex to reverse residual neuromuscular blockade and facilitate neurologic examination in an adolescent trauma patient in the Pediatric ICU setting.
by: T. Renner, et al.
Published: (2023) -
Reevaluation and update on efficacy and safety of neostigmine for reversal of neuromuscular blockade
by: Luo J, et al.
Published: (2018) -
Effects of Sugammadex versus Neostigmine on Intraoperative Coagulation Profiles in Patients with Thyroidectomy
by: Zhao D, et al.
Published: (2021) -
Impact of Neostigmine and Sugammadex on Time to Leaving the Operating Room in a Community Hospital
by: Julie John, et al.
Published: (2020)